Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.60) by 3.33 percent. This is a 3.33 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $2.451 million which beat the analyst consensus estimate of $1.920 million by 27.63 percent. This is a 1.62 percent increase over sales of $2.412 million the same period last year.